Phosphodiester Silybin Dimers Powerful Radical Scavengers: A Antiproliferative Activity on Different Cancer Cell Lines
Silibinin is the main biologically active component of silymarin extract and consists of a mixture 1:1 of two diastereoisomeric flavonolignans, namely silybin A ( ) and silybin B ( ), which we call here silybins. Despite the high interest in the activity of this flavonolignan, there are still few st...
Saved in:
Published in | Molecules (Basel, Switzerland) Vol. 27; no. 5; p. 1702 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
05.03.2022
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Silibinin is the main biologically active component of silymarin extract and consists of a mixture 1:1 of two diastereoisomeric flavonolignans, namely silybin A (
) and silybin B (
), which we call here silybins. Despite the high interest in the activity of this flavonolignan, there are still few studies that give due attention to the role of its stereochemistry and, there is still today a strong need to investigate in this area. In this regard, here we report a study concerning the radical scavenger ability and the antiproliferative activity on different cell lines, both of silybins and phosphodiester-linked silybin dimers. An efficient synthetic strategy to obtain silybin dimers in an optical pure form (
,
and
) starting from a suitable building block of silybin A and silybin B, obtained by us from natural extract silibinin, was proposed. New dimers show strong antioxidant properties, determined through hydroxyl radical (HO
) scavenging ability, comparable to the value reported for known potent antioxidants such as quercetin. A preliminary screening was performed by treating cells with 10 and 50 μM concentrations for 48 h to identify the most sensitive cell lines. The results show that silibinin compounds were active on Jurkat, A375, WM266, and HeLa, but at the tested concentrations, they did not interfere with the growth of PANC, MCF-7, HDF or U87. In particular, both monomers (
and
) and dimers (
,
and
) present selective anti-proliferative activity towards leukemia cells in the mid-micromolar range and are poorly active on normal cells. They exhibit different mechanisms of action in fact all the cells treated with the
and
go completely into apoptosis, whereas only part of the cells treated with
and
were found to be in apoptosis. |
---|---|
AbstractList | Silibinin is the main biologically active component of silymarin extract and consists of a mixture 1:1 of two diastereoisomeric flavonolignans, namely silybin A (
1a
) and silybin B (
1b
), which we call here silybins. Despite the high interest in the activity of this flavonolignan, there are still few studies that give due attention to the role of its stereochemistry and, there is still today a strong need to investigate in this area. In this regard, here we report a study concerning the radical scavenger ability and the antiproliferative activity on different cell lines, both of silybins and phosphodiester-linked silybin dimers. An efficient synthetic strategy to obtain silybin dimers in an optical pure form (
6aa
,
6ab
and
6bb
) starting from a suitable building block of silybin A and silybin B, obtained by us from natural extract silibinin, was proposed. New dimers show strong antioxidant properties, determined through hydroxyl radical (HO
●
) scavenging ability, comparable to the value reported for known potent antioxidants such as quercetin. A preliminary screening was performed by treating cells with 10 and 50 μM concentrations for 48 h to identify the most sensitive cell lines. The results show that silibinin compounds were active on Jurkat, A375, WM266, and HeLa, but at the tested concentrations, they did not interfere with the growth of PANC, MCF-7, HDF or U87. In particular, both monomers (
1a
and
1b
) and dimers (
6aa
,
6ab
and
6bb
) present selective anti-proliferative activity towards leukemia cells in the mid-micromolar range and are poorly active on normal cells. They exhibit different mechanisms of action in fact all the cells treated with the
1a
and
1b
go completely into apoptosis, whereas only part of the cells treated with
6aa
and
6ab
were found to be in apoptosis. Silibinin is the main biologically active component of silymarin extract and consists of a mixture 1:1 of two diastereoisomeric flavonolignans, namely silybin A ( ) and silybin B ( ), which we call here silybins. Despite the high interest in the activity of this flavonolignan, there are still few studies that give due attention to the role of its stereochemistry and, there is still today a strong need to investigate in this area. In this regard, here we report a study concerning the radical scavenger ability and the antiproliferative activity on different cell lines, both of silybins and phosphodiester-linked silybin dimers. An efficient synthetic strategy to obtain silybin dimers in an optical pure form ( , and ) starting from a suitable building block of silybin A and silybin B, obtained by us from natural extract silibinin, was proposed. New dimers show strong antioxidant properties, determined through hydroxyl radical (HO ) scavenging ability, comparable to the value reported for known potent antioxidants such as quercetin. A preliminary screening was performed by treating cells with 10 and 50 μM concentrations for 48 h to identify the most sensitive cell lines. The results show that silibinin compounds were active on Jurkat, A375, WM266, and HeLa, but at the tested concentrations, they did not interfere with the growth of PANC, MCF-7, HDF or U87. In particular, both monomers ( and ) and dimers ( , and ) present selective anti-proliferative activity towards leukemia cells in the mid-micromolar range and are poorly active on normal cells. They exhibit different mechanisms of action in fact all the cells treated with the and go completely into apoptosis, whereas only part of the cells treated with and were found to be in apoptosis. Silibinin is the main biologically active component of silymarin extract and consists of a mixture 1:1 of two diastereoisomeric flavonolignans, namely silybin A (1a) and silybin B (1b), which we call here silybins. Despite the high interest in the activity of this flavonolignan, there are still few studies that give due attention to the role of its stereochemistry and, there is still today a strong need to investigate in this area. In this regard, here we report a study concerning the radical scavenger ability and the antiproliferative activity on different cell lines, both of silybins and phosphodiester-linked silybin dimers. An efficient synthetic strategy to obtain silybin dimers in an optical pure form (6aa, 6ab and 6bb) starting from a suitable building block of silybin A and silybin B, obtained by us from natural extract silibinin, was proposed. New dimers show strong antioxidant properties, determined through hydroxyl radical (HO●) scavenging ability, comparable to the value reported for known potent antioxidants such as quercetin. A preliminary screening was performed by treating cells with 10 and 50 μM concentrations for 48 h to identify the most sensitive cell lines. The results show that silibinin compounds were active on Jurkat, A375, WM266, and HeLa, but at the tested concentrations, they did not interfere with the growth of PANC, MCF-7, HDF or U87. In particular, both monomers (1a and 1b) and dimers (6aa, 6ab and 6bb) present selective anti-proliferative activity towards leukemia cells in the mid-micromolar range and are poorly active on normal cells. They exhibit different mechanisms of action in fact all the cells treated with the 1a and 1b go completely into apoptosis, whereas only part of the cells treated with 6aa and 6ab were found to be in apoptosis. |
Author | Di Fabio, Giovanni Capasso, Domenica Di Gaetano, Sonia Romanucci, Valeria Pagano, Rita Lembo, Antonio Zarrelli, Armando |
AuthorAffiliation | 4 Institute of Biostructures and Bioimaging-CNR, Via Mezzocannone 16, 80134 Napoli, Italy 3 Center for Life Sciences and Technologies (CESTEV), University of Naples “Federico II“, Via De Amicis 95, 80145 Napoli, Italy 1 Department of Chemical Sciences, University of Naples Federico II, Via Cintia 4, 80126 Napoli, Italy; valeria.romanucci@unina.it (V.R.); rita.pagano@unina.it (R.P.); antonio.lembo@unina.it (A.L.); zarrelli@unina.it (A.Z.) 5 AIPRAS Onlus (Associazione Italiana per la Promozione delle Ricerche sull’Ambiente e la Salute umana Onlus), Via Campellone 50, 82030 Dugenta, Italy 2 Interuniversity Research Centre on Bioactive Peptides (CIRPeB), University of Naples “Federico II“, Via Mezzocannone 16, 80134 Napoli, Italy; domenica.capasso@unina.it (D.C.); digaetan@unina.it (S.D.G.) |
AuthorAffiliation_xml | – name: 5 AIPRAS Onlus (Associazione Italiana per la Promozione delle Ricerche sull’Ambiente e la Salute umana Onlus), Via Campellone 50, 82030 Dugenta, Italy – name: 4 Institute of Biostructures and Bioimaging-CNR, Via Mezzocannone 16, 80134 Napoli, Italy – name: 3 Center for Life Sciences and Technologies (CESTEV), University of Naples “Federico II“, Via De Amicis 95, 80145 Napoli, Italy – name: 2 Interuniversity Research Centre on Bioactive Peptides (CIRPeB), University of Naples “Federico II“, Via Mezzocannone 16, 80134 Napoli, Italy; domenica.capasso@unina.it (D.C.); digaetan@unina.it (S.D.G.) – name: 1 Department of Chemical Sciences, University of Naples Federico II, Via Cintia 4, 80126 Napoli, Italy; valeria.romanucci@unina.it (V.R.); rita.pagano@unina.it (R.P.); antonio.lembo@unina.it (A.L.); zarrelli@unina.it (A.Z.) |
Author_xml | – sequence: 1 givenname: Valeria orcidid: 0000-0003-0317-5140 surname: Romanucci fullname: Romanucci, Valeria organization: Department of Chemical Sciences, University of Naples Federico II, Via Cintia 4, 80126 Napoli, Italy – sequence: 2 givenname: Rita orcidid: 0000-0002-9402-389X surname: Pagano fullname: Pagano, Rita organization: Department of Chemical Sciences, University of Naples Federico II, Via Cintia 4, 80126 Napoli, Italy – sequence: 3 givenname: Antonio surname: Lembo fullname: Lembo, Antonio organization: Department of Chemical Sciences, University of Naples Federico II, Via Cintia 4, 80126 Napoli, Italy – sequence: 4 givenname: Domenica orcidid: 0000-0001-7201-3431 surname: Capasso fullname: Capasso, Domenica organization: Center for Life Sciences and Technologies (CESTEV), University of Naples "Federico II", Via De Amicis 95, 80145 Napoli, Italy – sequence: 5 givenname: Sonia orcidid: 0000-0001-5523-3619 surname: Di Gaetano fullname: Di Gaetano, Sonia organization: Institute of Biostructures and Bioimaging-CNR, Via Mezzocannone 16, 80134 Napoli, Italy – sequence: 6 givenname: Armando orcidid: 0000-0001-7866-821X surname: Zarrelli fullname: Zarrelli, Armando organization: Department of Chemical Sciences, University of Naples Federico II, Via Cintia 4, 80126 Napoli, Italy – sequence: 7 givenname: Giovanni orcidid: 0000-0003-2912-4827 surname: Di Fabio fullname: Di Fabio, Giovanni organization: AIPRAS Onlus (Associazione Italiana per la Promozione delle Ricerche sull'Ambiente e la Salute umana Onlus), Via Campellone 50, 82030 Dugenta, Italy |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35268803$$D View this record in MEDLINE/PubMed |
BookMark | eNplkk1vEzEQhleoiH7AD-CCLHHpJcUf6_UuB6QofFWKREXhbNneceLIawd7Nyj_Hoe0VQunsWbeeTTzes6rkxADVNVrgq8Y6_C7IXowk4dMBeZEYPqsOiM1xTOG6-7k0fu0Os95gzElNeEvqlPGadO2mJ1Vu5t1zNt17B3kERK6dX6vXUAf3QApo5v4G5KdPPquemeUR7dG7SCsSu09mqN5GN02Re8sJDW6HaC5KcGNexQPDFvyEEa0UMEU-AK8R0sXIL-snlvlM7y6ixfVz8-ffiy-zpbfvlwv5suZqWs-zoympNcECG7K6L0FxqGzWlusG1O3Qhjeaa6UrjVT2nYGWkxrIxhXteK2YxfV9ZHbR7WR2-QGlfYyKif_JmJaSZVGZzxIzayw0DGhRUFj1fXYKtGIhraNbWldWB-OrO2kB-hNWSwp_wT6tBLcWq7iTrYdIULwAri8A6T4ayp-y8FlUzxRAeKUJW1YKygv_1Wkb_-RbuKUQrHqoCqwtqOsqMhRZVLMOYF9GIZgebgQ-d-FlJ43j7d46Lg_CfYHOaq9sw |
Cites_doi | 10.1039/D1QO00045D 10.1016/j.ejmech.2016.07.070 10.3390/antiox8070236 10.1021/bi101731d 10.1055/s-0032-1328703 10.1016/S0031-9422(00)83860-1 10.1002/anie.201000044 10.1016/j.ejmech.2019.06.010 10.1016/j.bioorg.2018.01.026 10.2174/092986707779941159 10.1021/acschemneuro.0c00232 10.1002/hlca.201400282 10.1021/acs.jmedchem.8b00834 10.3390/molecules22081323 10.1039/C7MB00190H 10.1016/j.tetlet.2013.09.035 10.1055/s-0032-1317688 10.1371/journal.pone.0106441 10.3390/ijms22157885 10.1021/jp075814h 10.1016/j.abb.2019.05.009 10.1039/C3NP70122K 10.1016/j.bmcl.2011.06.049 10.1021/np030414g 10.1016/j.freeradbiomed.2008.11.016 10.1021/acschemneuro.7b00110 10.2174/092986706775197908 10.3390/ijms12084861 10.1021/jm400970m 10.3390/molecules24010108 10.1021/acs.jmedchem.9b00262 10.1016/j.bmcl.2014.10.023 |
ContentType | Journal Article |
Copyright | 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 by the authors. 2022 |
Copyright_xml | – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 by the authors. 2022 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.3390/molecules27051702 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Health Medical collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Access via ProQuest (Open Access) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 7X7 name: Health Medical collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1420-3049 |
ExternalDocumentID | oai_doaj_org_article_b3f7fe937b7c480a9d0fa7676286f824 10_3390_molecules27051702 35268803 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 123 2WC 3V. 53G 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ A8Z AADQD AAFWJ AAHBH ABDBF ABJCF ABUWG ACGFO ACIWK ACPRK AEGXH AENEX AFKRA AFPKN AFRAH AFZYC AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS BBNVY BENPR BHPHI BPHCQ BVXVI CCPQU CGR CS3 CUY CVF D1I DIK DU5 E3Z EBD ECM EIF EMOBN ESTFP ESX FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE HZ~ I09 IAO ITC KB. KQ8 LK8 M1P M7P MODMG M~E NPM O-U O9- OK1 P2P PDBOC PIMPY PQQKQ PROAC PSQYO RIG RPM SV3 TR2 TUS UKHRP ~8M AAYXX CITATION 7XB 8FK AZQEC DWQXO K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c445t-cb21db1e106214dfe35e9fbbf0b6c4877c59b5aab4b3abf9ce8024c735a4a5f93 |
IEDL.DBID | RPM |
ISSN | 1420-3049 |
IngestDate | Tue Oct 22 14:42:50 EDT 2024 Tue Sep 17 21:21:52 EDT 2024 Sat Oct 26 00:18:30 EDT 2024 Sat Nov 09 09:41:48 EST 2024 Thu Sep 26 21:06:40 EDT 2024 Sat Sep 28 08:20:23 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | radical scavenger of ROS apoptosis silibinin leukemia cells flavonolignan dimers silybin |
Language | English |
License | Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c445t-cb21db1e106214dfe35e9fbbf0b6c4877c59b5aab4b3abf9ce8024c735a4a5f93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-7866-821X 0000-0001-5523-3619 0000-0003-2912-4827 0000-0003-0317-5140 0000-0001-7201-3431 0000-0002-9402-389X |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911775/ |
PMID | 35268803 |
PQID | 2637758923 |
PQPubID | 2032355 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_b3f7fe937b7c480a9d0fa7676286f824 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8911775 proquest_miscellaneous_2638725049 proquest_journals_2637758923 crossref_primary_10_3390_molecules27051702 pubmed_primary_35268803 |
PublicationCentury | 2000 |
PublicationDate | 20220305 |
PublicationDateYYYYMMDD | 2022-03-05 |
PublicationDate_xml | – month: 3 year: 2022 text: 20220305 day: 5 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Molecules (Basel, Switzerland) |
PublicationTitleAlternate | Molecules |
PublicationYear | 2022 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Wong (ref_6) 2018; 61 Zarrelli (ref_19) 2011; 21 ref_13 Romanucci (ref_21) 2013; 79 Cillard (ref_24) 1987; 26 ref_30 Lee (ref_9) 2003; 66 Trouillas (ref_25) 2008; 112 Ge (ref_28) 2011; 12 Berube (ref_4) 2006; 13 Si (ref_29) 2019; 671 ref_17 Iadonisi (ref_31) 2021; 8 Thapa (ref_5) 2011; 50 Quideau (ref_3) 2011; 50 Zarrelli (ref_15) 2014; 24 Romanucci (ref_14) 2018; 77 Biedermann (ref_10) 2014; 31 Zarrelli (ref_20) 2012; 24 Romanucci (ref_16) 2013; 54 Gazak (ref_11) 2007; 14 Guo (ref_27) 2021; 12 Capasso (ref_33) 2017; 13 Polachi (ref_12) 2016; 123 Ahmed (ref_22) 2020; 11 Pelliccia (ref_32) 2020; 63 Zarrelli (ref_18) 2015; 98 Neha (ref_1) 2019; 178 Rosini (ref_2) 2014; 57 ref_8 Sciacca (ref_23) 2017; 8 ref_7 Sedmera (ref_26) 2009; 46 |
References_xml | – volume: 8 start-page: 1823 year: 2021 ident: ref_31 article-title: Switchable synthesis of glycosyl selenides or diselenides with direct use of selenium as the selenating agent publication-title: Org. Chem. Front. doi: 10.1039/D1QO00045D contributor: fullname: Iadonisi – volume: 123 start-page: 577 year: 2016 ident: ref_12 article-title: Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer—A comprehensive review publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2016.07.070 contributor: fullname: Polachi – ident: ref_17 doi: 10.3390/antiox8070236 – volume: 50 start-page: 2445 year: 2011 ident: ref_5 article-title: Biflavonoids Are Superior to Monoflavonoids in Inhibiting Amyloid-β Toxicity and Fibrillogenesis via Accumulation of Nontoxic Oligomer-like Structures publication-title: Biochemistry doi: 10.1021/bi101731d contributor: fullname: Thapa – volume: 12 start-page: 736 year: 2021 ident: ref_27 article-title: Inhibition of TMEM16A by Natural Product Silibinin: Potential Lead Compounds for Treatment of Lung Adenocarcinoma publication-title: Front. Pharmacol. contributor: fullname: Guo – volume: 79 start-page: 1077 year: 2013 ident: ref_21 article-title: A Rapid and Simple Chromatographic Separation of Diastereomers of Silibinin and Their Oxidation to Produce 2,3-Dehydrosilybin Enantiomers in an Optically Pure Form publication-title: Planta Med. doi: 10.1055/s-0032-1328703 contributor: fullname: Romanucci – volume: 26 start-page: 2489 year: 1987 ident: ref_24 article-title: Hydroxyl radical scavenging activity of flavonoids publication-title: Phytochemistry doi: 10.1016/S0031-9422(00)83860-1 contributor: fullname: Cillard – volume: 50 start-page: 586 year: 2011 ident: ref_3 article-title: Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis publication-title: Angew. Chemie Int. Ed. doi: 10.1002/anie.201000044 contributor: fullname: Quideau – volume: 178 start-page: 687 year: 2019 ident: ref_1 article-title: Medicinal prospects of antioxidants: A review publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2019.06.010 contributor: fullname: Neha – volume: 77 start-page: 349 year: 2018 ident: ref_14 article-title: Silibinin phosphodiester glyco-conjugates: Synthesis, redox behaviour and biological investigations publication-title: Bioorg. Chem. doi: 10.1016/j.bioorg.2018.01.026 contributor: fullname: Romanucci – volume: 14 start-page: 315 year: 2007 ident: ref_11 article-title: Silybin and Silymarin—New and Emerging Applications in Medicine publication-title: Curr. Med. Chem. doi: 10.2174/092986707779941159 contributor: fullname: Gazak – volume: 11 start-page: 2566 year: 2020 ident: ref_22 article-title: Trehalose Conjugates of silybin as prodrugs for targeting toxic Aβ aggregates publication-title: ACS Chem. Neurosci. doi: 10.1021/acschemneuro.0c00232 contributor: fullname: Ahmed – volume: 98 start-page: 399 year: 2015 ident: ref_18 article-title: Synthesis of New Silybin Derivatives and Evaluation of Their Antioxidant Properties publication-title: Helv. Chim. Acta doi: 10.1002/hlca.201400282 contributor: fullname: Zarrelli – volume: 61 start-page: 9931 year: 2018 ident: ref_6 article-title: Discovery of Novel Flavonoid Dimers to Reverse Multidrug Resistance Protein 1 (MRP1, ABCC1) Mediated Drug Resistance in Cancers Using a High Throughput Platform with “Click Chemistry” publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.8b00834 contributor: fullname: Wong – ident: ref_8 doi: 10.3390/molecules22081323 – volume: 13 start-page: 1619 year: 2017 ident: ref_33 article-title: Unveiling a VEGF-mimetic peptide sequence in the IQGAP1 protein publication-title: Mol. Biosyst. doi: 10.1039/C7MB00190H contributor: fullname: Capasso – volume: 54 start-page: 6279 year: 2013 ident: ref_16 article-title: Microwave-assisted oxidation of silibinin: A simple and preparative method for the synthesis of improved radical scavengers publication-title: Tetrahedron Lett. doi: 10.1016/j.tetlet.2013.09.035 contributor: fullname: Romanucci – volume: 24 start-page: 45 year: 2012 ident: ref_20 article-title: New Silybin Scaffold for Chemical Diversification: Synthesis of Novel 23-Phosphodiester Silybin Conjugates publication-title: Synlett doi: 10.1055/s-0032-1317688 contributor: fullname: Zarrelli – ident: ref_30 doi: 10.1371/journal.pone.0106441 – ident: ref_13 doi: 10.3390/ijms22157885 – volume: 112 start-page: 1054 year: 2008 ident: ref_25 article-title: Mechanism of the Antioxidant Action of Silybin and 2,3-Dehydrosilybin Flavonolignans: A Joint Experimental and Theoretical Study publication-title: J. Phys. Chem. A doi: 10.1021/jp075814h contributor: fullname: Trouillas – volume: 671 start-page: 42 year: 2019 ident: ref_29 article-title: Silibinin-induced apoptosis of breast cancer cells involves mitochondrial impairment publication-title: Arch. Biochem. Biophys. doi: 10.1016/j.abb.2019.05.009 contributor: fullname: Si – volume: 31 start-page: 1138 year: 2014 ident: ref_10 article-title: Chemistry of silybin publication-title: Nat. Prod. Rep. doi: 10.1039/C3NP70122K contributor: fullname: Biedermann – volume: 21 start-page: 4389 year: 2011 ident: ref_19 article-title: New C-23 modified of silybin and 2,3-dehydrosilybin: Synthesis and preliminary evaluation of antioxidant properties publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2011.06.049 contributor: fullname: Zarrelli – volume: 66 start-page: 1632 year: 2003 ident: ref_9 article-title: Molecular Structure and Stereochemistry of Silybin A, Silybin B, Isosilybin A, and Isosilybin B, Isolated from Silybum marianum (Milk Thistle) publication-title: J. Nat. Prod. doi: 10.1021/np030414g contributor: fullname: Lee – volume: 46 start-page: 745 year: 2009 ident: ref_26 article-title: Molecular mechanisms of silybin and 2,3-dehydrosilybin antiradical activity—Role of individual hydroxyl groups publication-title: Free Radic. Biol. Med. doi: 10.1016/j.freeradbiomed.2008.11.016 contributor: fullname: Sedmera – volume: 8 start-page: 1767 year: 2017 ident: ref_23 article-title: Inhibition of Aβ Amyloid Growth and Toxicity by Silybins: The Crucial Role of Stereochemistry publication-title: ACS Chem. Neurosci. doi: 10.1021/acschemneuro.7b00110 contributor: fullname: Sciacca – volume: 13 start-page: 131 year: 2006 ident: ref_4 article-title: Natural and Synthetic Biologically Active Dimeric Molecules: Anticancer Agents, Anti-HIV Agents, Steroid Derivatives and Opioid Antagonists publication-title: Curr. Med. Chem. doi: 10.2174/092986706775197908 contributor: fullname: Berube – volume: 12 start-page: 4861 year: 2011 ident: ref_28 article-title: Silibinin Causes Apoptosis and Cell Cycle Arrest in Some Human Pancreatic Cancer Cells publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms12084861 contributor: fullname: Ge – volume: 57 start-page: 2821 year: 2014 ident: ref_2 article-title: Oxidative Stress in Alzheimer’s Disease: Are We Connecting the Dots? publication-title: J. Med. Chem. doi: 10.1021/jm400970m contributor: fullname: Rosini – ident: ref_7 doi: 10.3390/molecules24010108 – volume: 63 start-page: 2035 year: 2020 ident: ref_32 article-title: Bio-Inspired Dual-Selective BCL-2/c-MYC G-Quadruplex Binders: Design, Synthesis, and Anticancer Activity of Drug-like Imidazo[2,1- i]purine Derivatives publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.9b00262 contributor: fullname: Pelliccia – volume: 24 start-page: 5147 year: 2014 ident: ref_15 article-title: New silibinin glyco-conjugates: Synthesis and evaluation of antioxidant properties publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2014.10.023 contributor: fullname: Zarrelli |
SSID | ssj0021415 |
Score | 2.3951893 |
Snippet | Silibinin is the main biologically active component of silymarin extract and consists of a mixture 1:1 of two diastereoisomeric flavonolignans, namely silybin... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 1702 |
SubjectTerms | Alzheimer's disease Angiogenesis Antioxidants Antioxidants - chemistry Antioxidants - pharmacology Antiproliferatives Apoptosis Biological activity Cancer Cell cycle Cell Line Fibroblasts Flavonoids flavonolignan dimers Hydroxyl radicals Leukemia leukemia cells Metastasis Neoplasms Oxidative stress Quercetin radical scavenger of ROS Scavenging Silibinin silybin Silybin - pharmacology Silymarin Silymarin - chemistry Silymarin - pharmacology Stereochemistry Tumor cell lines |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1RT9swELYmXtgLYmOMbAwZaU-TIlI7jmPeSgEhtE0IhsRbZDs2rVSSiqaT-PfcxUlFAYkXXuMkcu4uvjvf-fsI-ZmVGWPODWKv87SlMIs1S01sJbOQfSQ2b-l8_vzNzq7T8xtx84TqC3vCAjxwENyB4V56B07USJvmiVZl4rXMJB6p9DkLSKCJ6pOpLtUagF8KNUwOSf3BXaCadXMmEZOq20PpvVAL1v9ahPm8UfKJ5zndJBtdyEiHYaqfyAdXfSbro56pbYv8vxjX89m4xoZAEBO9mkwfIOGlxxPclKYXSITmF1N6qduiDL2yyCF_C2OHdEiHVTOZIXePdwEFnA5toJSgNb4jEKg0dIT2cU9Hbjqlv7FZ_gu5Pj35NzqLOz6FGMQumtgaNijNwEEWCAIqvePCKW-MT0wGspXSCmWE1iY1XBuvrMvBg1vJhU618Ipvk7WqrtwOoaXhpYdQDWTJYak1Ki1dnjmupcosM2lEfvXyLWYBNqOAdAOVUbxQRkSOUAPLGxHxur0AdlB0dlC8ZQcR2e31V3S_4bxgGZeQEEEQG5H95TBoB6siunL1or0nlwjkpiLyNah7ORMkD4AFDp6WK4awMtXVkWoybkG6c4XlcPHtPb7tO_nI8NQFtr6JXbLW3C_cD4iFGrPXmv0jhawLzA priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT9swELcGe4CXaR_AytjkSXtCimjsOI73MnXdOjQBQnxIvEW2Y9NKXdK1KdL--905SaEM7TV2EuvufL4v34-QT2mRMuZcHHmdJQHCLNIsMZGVzIL30bdZgPM5PUuPr5OfN-KmDbgt2rLKTicGRV1UFmPkRyzlEmxbsEe-zH5HiBqF2dUWQmODPI-ZlOh8ZaMfK4crhtOpyWRycO2PfjWAs27BJHamaiMp3VkUWvY_ZWc-Lpd8cP6MXpIXreFIBw2nX5FnrnxNtoYdXtsbcnc-rhazcYVlgUAsejmZ_gG3l36bYGianiMcml9O6YUOqRl6aRFJ_hbGPtMBHZT1ZIYIPt41vcDpwDbAErTCbzQwKjUdopTM6dBNp_QES-Z3yPXo-9XwOGpRFSIgvqgja1hcmNiBLwgEKrzjwilvjO-b1IL7Iq1QRmhtEsO18cq6DM5xK7nQiRZe8V2yWVale0toYXjhwWADWnJQuEYlhctSx7VUqWUm6ZHDjr75rGmekYPTgczI_2FGj3xFDqwmYt_r8KCa3-btNsoN99I7MKmMhLX2tSr6XstU4gVbnzH440HHv7zdjIv8XnR65ONqGLiDuRFdumoZ5mQS27mpHtlr2L1aCUIIgJqDt-WaIKwtdX2knIxDq-5MYVJc7P9_We_INsNbFVjaJg7IZj1fuvdg69TmQxDovw85A3c priority: 102 providerName: ProQuest |
Title | Phosphodiester Silybin Dimers Powerful Radical Scavengers: A Antiproliferative Activity on Different Cancer Cell Lines |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35268803 https://www.proquest.com/docview/2637758923 https://search.proquest.com/docview/2638725049 https://pubmed.ncbi.nlm.nih.gov/PMC8911775 https://doaj.org/article/b3f7fe937b7c480a9d0fa7676286f824 |
Volume | 27 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELa28QAviN8ERmUknpCypnYSJ7x1YWVCbKo2JvUtsh17jZQmVZsi8d9z5yQVBZ54yUPsJKe7z_Gdfb6PkA9xETNmzMS3MgkdhZkvWah8LZiG6CPQiaPzubqOL-_Cr4tocUSi4SyMS9rXqjyrq9VZXS5dbuV6pcdDnth4fpUlKW41RuNjcgwAHUL0PsqawJTUbV9yiOfHq45l1myZwHJUAdLXYE14wC0_mItcyf5_-Zl_pkv-Nv_MnpDHveNIp52AT8mRqZ-Rh9nA1_ac_Jgvm-162WBaICiL3pbVTwh76ecSl6bpHOnQ7K6iN9JtzdBbjUzy99D2iU7ptG7LNTL4WNPVAqdT3RFL0Abf0dGotDRDlGxoZqqKfsOU-RfkbnbxPbv0e1YFH5Qftb5WbFKoiYFYEHRVWMMjk1qlbKBiDeGL0FGqIilVqLhUNtUmgXlcCx7JUEY25S_JSd3U5jWhheKFBYcN1Mrhh6vSsDBJbLgUaayZCj3ycdBvvu6KZ-QQdKBd8r_s4pFztMC-I9a9djeazX3eWz9X3AprwKVSAmQNZFoEVopY4AFbmzD44ulgv7wfjNucxRzQkoAr65H3-2awDu6NyNo0O9cnEVjOLfXIq87ce0kGuHhEHADhQNTDFkCuK9XdI_XNfz_5ljxieOACs96iU3LSbnbmHbhBrRoB-BcCrsnsy4g8OL-4nt-M3JLCyA2IXw3WEL4 |
link.rule.ids | 230,315,730,783,787,867,888,2109,12068,12777,21400,27936,27937,31731,31732,33385,33386,33756,33757,43322,43612,43817,53804,53806,74073,74363,74630 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgexgvCDY-ysbwJJ6QorV2HMe8oFI2FdZNE9ukvkW2Y6-VStK1KRL_PXdO0q2AeI2dxLo7n-_L9yPkfZInjDnXi7xO4wBhFmkWm8hKZsH76No0wPmcXyTDm_jbWIybgNuyKatsdWJQ1HlpMUZ-zBIuwbYFe-TT_C5C1CjMrjYQGo_JNvbhQgQDOb53uHpwOtWZTA6u_fGPGnDWLZnEzlRNJKU9i0LL_n_ZmX-WSz44f06fkaeN4Uj7Naefk0eu2CU7gxavbY_8vJyUy_mkxLJAIBa9ms5-gdtLv0wxNE0vEQ7Nr2b0uw6pGXplEUn-FsY-0j7tF9V0jgg-3tW9wGnf1sAStMRv1DAqFR2glCzowM1mdIQl8y_IzenJ9WAYNagKERBfVJE1rJebngNfEAiUe8eFU94Y3zWJBfdFWqGM0NrEhmvjlXUpnONWcqFjLbziL8lWURbuNaG54bkHgw1oyUHhGhXnLk0c11Illpm4Qz609M3mdfOMDJwOZEb2FzM65DNyYD0R-16HB-XiNmu2UWa4l96BSWUkrLWrVd71WiYSL9j6lMEfD1r-Zc1mXGb3otMhR-th4A7mRnThylWYk0ps56Y65FXN7vVKEEIA1By8LTcEYWOpmyPFdBJadacKk-Lizf-X9Y7sDK_PR9no68XZPnnC8IYFlrmJA7JVLVbuLdg9lTkMwv0bQOQGWQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgSMDLxOfoGGAknpCitnYcx7yg0lENGFPFmNS3yHbstVJJSpsh8d9z5zgdBcRrnA_n7nwfvvP9CHmVlRljzg0Tr_M0QJglmqUmsZJZiD4GNg9wPp_PspOL9ONMzGL90yaWVXY6MSjqsra4R95nGZfg24I_0vexLGJ6PHm7-p4gghRmWiOcxk1yS0KUgjIvZ9fB1xAsVZvV5BDm97-14LNuwyR2qYq7Kp1dCu37_-Vz_lk6-Zstmtwj-9GJpKOW6_fJDVc9IHfGHXbbQ_JjOq83q3mNJYJAOHq-WP6EEJgeL3Cbmk4RGg3-j37RIU1Dzy2iyl_C2Bs6oqOqWawQzce7ti84HdkWZILW-I4WUqWhY5SYNR275ZKeYvn8I3Ixef91fJJEhIUEGCGaxBo2LM3QQVwIBCq948Ipb4wfmMxCKCOtUEZobVLDtfHKuhxsupVc6FQLr_hjslfVlXtCaGl46cF5A1pyUL5GpaXLM8e1VJllJu2R1x19i1XbSKOAAASZUfzFjB55hxzY3og9sMOFen1ZxCVVGO6ld-BeGQlzHWhVDryWmcTDtj5n8MWjjn9FXJib4lqMeuTldhi4g3kSXbn6KtyTS2ztpnrkoGX3diYIJwAqD56WO4KwM9XdkWoxD227c4UJcnH4_2m9ILdBrovTD2efnpK7DA9bYMWbOCJ7zfrKPQMXqDHPg2z_AkhRCpE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Phosphodiester+Silybin+Dimers+Powerful+Radical+Scavengers%3A+A+Antiproliferative+Activity+on+Different+Cancer+Cell+Lines&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=Romanucci%2C+Valeria&rft.au=Pagano%2C+Rita&rft.au=Lembo%2C+Antonio&rft.au=Capasso%2C+Domenica&rft.date=2022-03-05&rft.pub=MDPI+AG&rft.eissn=1420-3049&rft.volume=27&rft.issue=5&rft.spage=1702&rft_id=info:doi/10.3390%2Fmolecules27051702&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon |